secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001493152-24-030615
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity receives Nasdaq delisting notice; trading suspended August 5, 2024
-----------------------------------------------------------------------------

- Nasdaq Hearings Panel determined to delist Biotricity's common stock; trading suspended at open Aug 5, 2024.
- Non-compliance with minimum $35M market value of listed securities (MVLS) rule; compliance deadline extended to July 29, 2024.
- Company expects stock to be quoted on OTC Pink under symbol BTCY; also applied to OTCQB.
- Company has 15 days to request review of Panel's decision by Nasdaq Listing and Hearing Review Council.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224030615/0001493152-24-030615-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224030615/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-030615

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer